Cytoprotective effects of hesperetin and hesperidin against amyloid β-induced impairment of glucose transport through downregulation of neuronal autophagy

Molecular Nutrition and Food Research

Volumn 56, Issue 4, 2012, Pages 601-609

  Huang, Shang Ming ^a   Tsai, Shin Yi ^a   Lin, Jer An ^a   Wu, Chi Hao ^a   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Amyloid ; Autophagy; Glucose uptake; Hesperetin; Hesperidin

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); GLUCOSE; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; HESPERETIN; HESPERIDIN; MESSENGER RNA; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT; PROTEIN KINASE B; SLC2A3 PROTEIN, MOUSE; SLC2A4 PROTEIN, MOUSE;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; AUTOPHAGY; CELL LINE; CELL PROTECTION; CYTOLOGY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENERGY METABOLISM; GENETICS; METABOLISM; MOUSE; NERVE CELL; TRANSPORT AT THE CELLULAR LEVEL;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; AUTOPHAGY; BIOLOGICAL TRANSPORT; CELL LINE; CYTOPROTECTION; DOWN-REGULATION; ENERGY METABOLISM; GLUCOSE; GLUCOSE TRANSPORTER TYPE 3; GLUCOSE TRANSPORTER TYPE 4; HESPERIDIN; MICE; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER;

EID: 84859769676     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100682     Document Type: Article

References (36)

1. Querfurth, H. W., LaFerla, F. M., Alzheimer's disease. N. Engl. J. Med. 2010, 362, 329-344.
2. Hardy, J., Selkoe, D. J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297, 353-356.
3. Ott, A., Stolk, R. P., Hofman, A., van Harskamp, F. et al., Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 1996, 39, 1392-1397.
4. Hoyer, S., Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease causes and consequences: an update. Exp. Gerontol. 2000, 35, 1363-1372.
5. de la Monte, S. M., Wands, J. R., Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J. Alzheimers Dis. 2005, 7, 45-61.
6. Park, C. R., Cognitive effects of insulin in the central nervous system. Neurosci. Biobehav. Rev. 2001, 25, 311-323.
7. Ma, Q. L., Yang, F., Rosario, E. R., Ubeda, O. J. et al., Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J. Neurosci. 2009, 29, 9078-9089.
8. Lee, H. K., Kumar, P., Fu, Q., Rosen, K. M. et al., The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid. Mol. Biol. Cell. 2009, 20, 1533-1544.
9. Eskelinen, E. L., Saftig, P., Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochimica. Biophysica. Acta 2009, 1793, 664-673.
10. He, C., Klionsky, D. J., Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009, 43, 67-93.
11. Wong, E., Cuervo, A. M., Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 2010, 13, 805-811.
12. Bu, L., Lephart, E. D., Soy isoflavones modulate the expression of BAD and neuron-specific beta III tubulin in male rat brain. Neurosci. Lett. 2005, 385, 153-157.
13. Yoon, I., Lee, K. H., Cho, J., Gossypin protects primary cultured rat cortical cells from oxidative stress- and beta-amyloid-induced toxicity. Arch. Pharm. Res. 2004, 27, 454-459.
14. Weinreb, O., Mandel, S., Amit, T., Youdim, M. B., Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J. Nutr. Biochem. 2004, 15, 506-516.
15. Rainey-Smith, S., Schroetke, L. W., Bahia, P., Fahmi, A. et al., Neuroprotective effects of hesperetin in mouse primary neurones are independent of CREB activation. Neurosci. Lett. 2008, 438, 29-33.
16. Manach, C., Morand, C., Gil-Izquierdo, A., Bouteloup-Demange, C. et al., Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur. J. Clin. Nutr. 2003, 57, 235-242.
17. Youdim, K. A., Dobbie, M. S., Kuhnle, G., Proteggente, A. R. et al., Interaction between flavonoids and the blood-brain barrier: in vitro studies. J. Neurochem. 2003, 85, 180-192.
18. De Strooper, B., Vassar, R., Golde, T., The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 2010, 6, 99-107.
19. Li, Q. X., Fuller, S. J., Beyreuther, K., Masters, C. L., The amyloid precursor protein of Alzheimer disease in human brain and blood. J. Leukoc. Biol. 1999, 66, 567-574.
20. Mielke, J. G., Wang, Y. T., Insulin, synaptic function, and opportunities for neuroprotection. Prog. Mol. Biol. Transl. Sci. 2011, 98, 133-186.
21. Schubert, D., Glucose metabolism and Alzheimer's disease. Ageing Res. Rev. 2005, 4, 240-257.
22. Dumurgier, J., Paquet, C., Peoc'h, K., Lapalus, P. et al., CSF Aβ1-42 levels and glucose metabolism in Alzheimer's disease. J. Alzheimers Dis. 2011, 26, 1-7.
23. LaFerla, F. M., Green, K. N., Oddo, S., Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 2007, 8, 499-509.
24. Dumurgier, J., Paquet, C., Benisty, S., Kiffel, C. et al., Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: the cognitive reserve theory. Neurobiol. Dis. 2010, 40, 456-459.
25. McEwen, B. S., Reagan, L. P., Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur. J. Pharmacol. 2004, 490, 13-24.
26. Duelli, R., Kuschinsky, W., Brain glucose transporters: relationship to local energy demand. News Physiol. Sci. 2001, 16, 71-76.
27. Haber, R. S., Weinstein, S. P., O'Boyle, E., Morgello, S., Tissue distribution of the human GLUT3 glucose transporter. Endocrinology 1993, 132, 2538-2543.
28. Mooradian, A. D., Chung, H. C., Shah, G. N., GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol. Aging 1997, 18, 469-474.
29. Mobasheri, A., Richardson, S., Mobasheri, R., Shakibaei, M. et al., Hypoxia inducible factor-1 and facilitative glucose transporters GLUT1 and GLUT3: putative molecular components of the oxygen and glucose sensing apparatus in particular chondrocytes. Histol. Histopathol. 2005, 20, 1327-1338.
30. Liu, Y., Liu, F., Iqbal, K., Grundke-Iqbal, I. et al., Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett. 2008, 582, 359-364.
31. Foley, K., Boguslavsky, S., Klip, A., Endocytosis, recycling, and regulated exocytosis of glucose transporter 4. Biochemistry 2011, 50, 3048-3061.
32. Reagan, L. P., Glucose, stress, and hippocampal neuronal vulnerability. Int. Rev. Neurobiol. 2002, 51, 289-324.
33. Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M. et al., Macroautophagy-a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease.J. Cell. Biol. 2005, 171, 87-98.
34. Wilson, C. A., Murphy, D. D., Giasson, B. I., Zhang, B. et al., Degradative organelles containing mislocalized alpha and beta-synuclein proliferate in presenilin-1 null neurons. J. Cell. Biol. 2004, 165, 335-346.
35. Martinez-Vicente, M., Cuervo, A. M., Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol. 2007, 6, 352-361.
36. Jaeger, P. A., Wyss-Coray, T., All-you-can-eat: autophagy in neurodegeneration and neuroprotection. Mol. Neurodegener. 2009, 4, 16-37.